These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9736425)
21. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836 [TBL] [Abstract][Full Text] [Related]
22. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression. Ohshima K; Haraoka S; Fujiki T; Yoshioka S; Suzumiya J; Kanda M; Kikuchi M Pathol Int; 1999 Jun; 49(6):506-12. PubMed ID: 10469393 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis. Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561 [TBL] [Abstract][Full Text] [Related]
24. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
25. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma. McDonald JW; Pilgram TK Histopathology; 1999 May; 34(5):439-46. PubMed ID: 10231419 [TBL] [Abstract][Full Text] [Related]
26. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pasz-Walczak G; Kordek R; Faflik M Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890 [TBL] [Abstract][Full Text] [Related]
27. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. Warnakulasuriya KA; Tavassoli M; Johnson NW J Oral Pathol Med; 1998 Sep; 27(8):376-81. PubMed ID: 9736426 [TBL] [Abstract][Full Text] [Related]
28. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression. Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118 [TBL] [Abstract][Full Text] [Related]
29. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas. Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723 [TBL] [Abstract][Full Text] [Related]
30. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530 [TBL] [Abstract][Full Text] [Related]
31. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320 [TBL] [Abstract][Full Text] [Related]
32. p21{Waf1/CIP1} is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis. Pérez-Sayáns M; Suárez-Peñaranda JM; Iruegas EP; de Almeida MR; Barros-Angueira F; Torreira MG; García-García A Cancer Biomark; 2015; 15(1):19-26. PubMed ID: 25524938 [TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related]
34. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201 [TBL] [Abstract][Full Text] [Related]
35. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754 [TBL] [Abstract][Full Text] [Related]
36. Differential modulation of zinc-stimulated p21(Cip/WAF1) and cyclin D1 induction by inhibition of PI3 kinase in HT-29 colorectal cancer cells. Oh SY; Park KS; Kim JA; Choi KY Exp Mol Med; 2002 Mar; 34(1):27-31. PubMed ID: 11989975 [TBL] [Abstract][Full Text] [Related]
37. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells. Park US; Park SK; Lee YI; Park JG; Lee YI Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]